LENZ Therapeutics (LENZ) Tax Provisions (2024 - 2025)
LENZ Therapeutics (LENZ) reported Tax Provisions of $2000.0 for Q4 2025, up 100.0% year-over-year from $1000.0 in Q4 2024, and down 99.6% on a QoQ basis from $500000.0 in Q2 2025.
LENZ Therapeutics (LENZ) has 2 years of Tax Provisions data on file, last reported at $2000.0 in Q4 2025.
- Quarterly Tax Provisions rose 100.0% year-over-year to $2000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $503000.0 (changed N/A YoY) and the FY2025 annual result came in at $502000.0, up 50100.0% from the prior year.
- Tax Provisions eased to $2000.0 in Q4 2025 per LENZ's latest filing, from $500000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $500000.0 in Q2 2025 and bottomed at $1000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.66 Mn |
| 10 | LENZ Therapeutics | 235.77 Mn | 235.77 Mn | 825,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,000.00 |
| Jun 30, 2025 | 500,000.00 |
| Dec 31, 2024 | 1,000.00 |